FDA Reviewing Benefits Of Blood Thinner Plavix

By: Associated Press Email
By: Associated Press Email

Stay up-to-date with KAKE News:

Monday, January 26, 2009

Federal health officials are investigating whether the blockbuster blood thinner Plavix is less effective in some patients.

The Food and Drug Administration is studying reports that taking certain heartburn medications alongside Plavix decreases the benefits of the drug. The FDA is also investigating whether patients' genetic background can interfere with effectiveness.

Plavix is the second-best-selling drug in the world. It is marketed by Bristol-Myers Squibb Co. and Sanofi-Aventis SA.

The companies have agreed to study the effects of genetic factors or heartburn drugs. The studies will take several months to complete.

Until more information is available, the FDA says patients should continue taking Plavix.


Comments are posted from viewers like you and do not always reflect the views of this station.
powered by Disqus
KAKE TV 1500 N. West Street Wichita, KS 67203-1323 (316) 943-4221
Gray Television, Inc. - Copyright © 2002-2014 - Designed by Gray Digital Media - Powered by Clickability 38327204 - kake.com/a?a=38327204